-
Je něco špatně v tomto záznamu ?
Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation
T. Lamberska, E. Settelmayerova, J. Smisek, M. Luksova, G. Maloskova, R. Plavka,
Jazyk angličtina Země Norsko
Typ dokumentu klinické zkoušky kontrolované, časopisecké články
PubMed
28871620
DOI
10.1111/apa.14060
Knihovny.cz E-zdroje
- MeSH
- biologické přípravky aplikace a dávkování MeSH
- fosfolipidy aplikace a dávkování MeSH
- intratracheální intubace využití MeSH
- lidé MeSH
- novorozenci extrémně nezralí MeSH
- novorozenec MeSH
- plicní surfaktanty aplikace a dávkování MeSH
- resuscitace metody MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky kontrolované MeSH
AIM: Minimally aggressive and easily performed techniques that facilitate spontaneous respiratory stabilisation are required to reduce rescue intubation in extremely premature infants. This study evaluated the feasibility and safety of administering surfactant into the pharynx of infants born at <25 weeks immediately after birth. METHODS: This study of 19 infants was conducted from January 2013 to June 2014 in a tertiary perinatal centre in Prague. We administered 1.5 mL of Curosurf as a bolus into the pharynx and simultaneously performed a sustained inflation manoeuvre (SIM). The extent of the interventions, death and severe neonatal morbidity in the study group were compared with 20 controls born before the study period and 20 born after it. RESULTS: All infants received oropharyngeal surfactant within the median (interquartile range) time of 40 seconds (25-75) after cord camping. The surfactant had to be suctioned in one infant because of upper airway obstruction. Although more subsequent surfactant was administered in the study group, significantly fewer study period infants required intubation than the before and after controls (16% versus 75% and 58%, respectively, p < 0.01). CONCLUSION: Oropharyngeal surfactant with simultaneous SIM was feasible and safe and reduced the need for delivery room intubation in these fragile infants.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033741
- 003
- CZ-PrNML
- 005
- 20250924075001.0
- 007
- ta
- 008
- 181008s2018 no f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/apa.14060 $2 doi
- 035 __
- $a (PubMed)28871620
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a no
- 100 1_
- $a Lamberská, Tereza $u Division of Neonatology, Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $7 xx0335270
- 245 10
- $a Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation / $c T. Lamberska, E. Settelmayerova, J. Smisek, M. Luksova, G. Maloskova, R. Plavka,
- 520 9_
- $a AIM: Minimally aggressive and easily performed techniques that facilitate spontaneous respiratory stabilisation are required to reduce rescue intubation in extremely premature infants. This study evaluated the feasibility and safety of administering surfactant into the pharynx of infants born at <25 weeks immediately after birth. METHODS: This study of 19 infants was conducted from January 2013 to June 2014 in a tertiary perinatal centre in Prague. We administered 1.5 mL of Curosurf as a bolus into the pharynx and simultaneously performed a sustained inflation manoeuvre (SIM). The extent of the interventions, death and severe neonatal morbidity in the study group were compared with 20 controls born before the study period and 20 born after it. RESULTS: All infants received oropharyngeal surfactant within the median (interquartile range) time of 40 seconds (25-75) after cord camping. The surfactant had to be suctioned in one infant because of upper airway obstruction. Although more subsequent surfactant was administered in the study group, significantly fewer study period infants required intubation than the before and after controls (16% versus 75% and 58%, respectively, p < 0.01). CONCLUSION: Oropharyngeal surfactant with simultaneous SIM was feasible and safe and reduced the need for delivery room intubation in these fragile infants.
- 650 _2
- $a biologické přípravky $x aplikace a dávkování $7 D001688
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenci extrémně nezralí $7 D062071
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a intratracheální intubace $x využití $7 D007442
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a fosfolipidy $x aplikace a dávkování $7 D010743
- 650 _2
- $a plicní surfaktanty $x aplikace a dávkování $7 D011663
- 650 _2
- $a resuscitace $x metody $7 D012151
- 655 _2
- $a klinické zkoušky kontrolované $7 D018848
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Settelmayerova, Eva $u Division of Neonatology, Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Smisek, Jan $u Division of Neonatology, Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Luksova, Marketa $u Division of Neonatology, Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Maloskova, Gabriela $u Division of Neonatology, Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Plavka, Richard $u Division of Neonatology, Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00009036 $t Acta paediatrica (Oslo) $x 1651-2227 $g Roč. 107, č. 1 (2018), s. 73-78
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28871620 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20250924074956 $b ABA008
- 999 __
- $a ok $b bmc $g 1340976 $s 1030735
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 107 $c 1 $d 73-78 $e 20171004 $i 1651-2227 $m Acta paediatrica (Oslo) $n Acta Paediatr $x MED00009036
- LZP __
- $a Pubmed-20181008